Home / Fact sheets / Australia / Cervical quantitative data
Country fact sheet: Australia (Index year: )
Age group | 20-24 | 25-29 | 30-34 | 35-39 | 40-44 | 45-49 | 50-54 | 55-59 | 60-64 | 65-69 | 70-74 | 75-79 | Age unknown | Total |
Interval | ||||||||||||||
Screening interval (months) | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | ||||
Population (not personally invited) | ||||||||||||||
Target population | 941351 | 941524 | 847193 | 734278 | 732592 | 633293 | 605002 | 518879 | 440035 | 371420 | 6 765 567 | |||
Annual target population | 0 | 470 675 | 470 762 | 423 596 | 367 139 | 366 296 | 316 646 | 302 501 | 259 439 | 220 017 | 0 | 0 | 185 710 | 3 382 781 |
Women screened | 0 | 242 076 | 253 224 | 241 837 | 218 090 | 222 397 | 192 005 | 181 903 | 153 781 | 120 052 | 0 | 0 | 60 824 | 1 886 189 |
Examination coverage rate (%) | 0.0 | 51.4 | 53.8 | 57.1 | 59.4 | 60.7 | 60.6 | 60.1 | 59.3 | 54.6 | 0.0 | 0.0 | 32.8 | 55.8 |
Result (All tests in the year) | ||||||||||||||
Positive | 0 | 4 792 | 5 938 | 4 797 | 4 372 | 3 887 | 3 236 | 2 896 | 2 665 | 1 952 | 0 | 0 | 905 | 35 440 |
Negative | 0 | 237 284 | 247 286 | 237 040 | 213 718 | 218 510 | 188 769 | 179 007 | 151 116 | 118 100 | 0 | 0 | 59 919 | 1 850 749 |
Unknown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Referral for further assessment (%) | 0.0 | 2.0 | 2.3 | 2.0 | 2.0 | 1.7 | 1.7 | 1.6 | 1.7 | 1.6 | 0.0 | 0.0 | 1.5 | 1.9 |
Further assessment (all positive) | ||||||||||||||
Done | 0 | 2 913 | 3 816 | 3 159 | 2 762 | 2 377 | 2 018 | 1 802 | 1 709 | 1 252 | 0 | 0 | 580 | 22 388 |
Not done | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 0 | 1 879 | 2 122 | 1 638 | 1 610 | 1 510 | 1 218 | 1 094 | 956 | 700 | 0 | 0 | 325 | 13 052 |
Further assessment participation rate (%) | 0.0 | 60.8 | 64.3 | 65.9 | 63.2 | 61.2 | 62.4 | 62.2 | 64.1 | 64.1 | 0.0 | 0.0 | 64.1 | 63.2 |
Outcome (CIN 1, CIN 2 and CIN 3 separetely) | ||||||||||||||
No biopsy performed, no CIN nor ca detected | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No biopsy performed, treated on the basis of colpo diagnosis of CIN (see and treat) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unsatisfactory histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Carcinoma | 0 | 42 | 111 | 129 | 108 | 86 | 64 | 70 | 54 | 42 | 0 | 0 | 27 | 733 |
CIN3 / Adenocarcinoma in situ (CGIN) | 0 | 2 313 | 2 679 | 1 825 | 1 264 | 835 | 431 | 285 | 223 | 148 | 0 | 0 | 55 | 10 058 |
CIN2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIN1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other histology | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Unknown | 0 | 558 | 1 026 | 1 205 | 1 390 | 1 456 | 1 523 | 1 447 | 1 432 | 1 062 | 0 | 0 | 498 | 11 597 |